Gene Mutation and Endometrial Cancer Raleigh NC

A genetic marker for aggressive endometrial cancer has been identified by U.S. researchers, who said their finding could lead to more targeted and risk-appropriate treatments. The researchers, from the Washington University School of Medicine in St. Louis, found that genetic mutation of the ATR gene in tumors boosts the risk of cancer recurrence and death in women#r3 with a highly aggressive form of the disease known as endometrioid endometrial cancer.

Team Chiropractic & Sports Medicine - Raleigh
(919) 788-8881
309 W. Millbrook Road, Suite 199
Raleigh, NC

Data Provided by:
Glenn M Davis
(919) 785-1220
2304 Wesvill Court
Raleigh, NC
Specialties
Cosmetic Surgery
Insurance
Medicare Accepted: No
Workmens Comp Accepted: No
Accepts Uninsured Patients: No
Emergency Care: No


Data Provided by:
Chiropractic Partners
(919) 787-8883
3700 Six Forks Rd
Raleigh, NC

Data Provided by:
Quail Corners Animal Hospital
(919) 876-0739
1613 E Millbrook Rd
Raleigh, NC

Data Provided by:
Hidden Valley Animal Hospital
(919) 847-9396
2315 Lynn Rd
Raleigh, NC

Data Provided by:
Roger B. Russell
(919) 785-0505
3633 Harden Road
Raleigh, NC
Specialties
Cosmetic Surgery
Insurance
Medicare Accepted: No
Workmens Comp Accepted: No
Accepts Uninsured Patients: No
Emergency Care: No


Data Provided by:
Johnson Chiropractic
(919) 876-2212
4412 Falls Of Neuse Rd
Raleigh, NC

Data Provided by:
Optimal Wellness Chiro - Dr. Loan Huynh
(919) 576-1423
4008 Barrett Dr., Suite 104
Raleigh, NC

Data Provided by:
Osborne Chiropractic Clinic
(919) 571-7311
5603 Duraleigh Rd
Raleigh, NC

Data Provided by:
Douglas Schmidt DC
(919) 576-1675
5500 McNeely Dr # 103
Raleigh, NC

Data Provided by:
Data Provided by:

Gene Mutation and Endometrial Cancer

Provided By:

WEDNESDAY, May 27 (HealthDay News) -- A genetic marker for aggressive endometrial cancer has been identified by U.S. researchers, who said their finding could lead to more targeted and risk-appropriate treatments.

The researchers, from the Washington University School of Medicine in St. Louis, found that genetic mutation of the ATR gene in tumors boosts the risk of cancer recurrence and death in women with a highly aggressive form of the disease known as endometrioid endometrial cancer.

The ATR gene directs cellular responses to DNA damage, the researchers noted.

"Women whose endometrial cancers have an ATR mutation have more than four times the risk of having their cancer return," study author Dr. Israel Zighelboim, a gynecologic oncologist, said in a news release from the university. "This and similar tumor biomarkers could potentially identify those patients most in danger of recurrence and guide the development of treatments aimed at these more aggressive tumors."

ATR mutations were found in about 5 percent of the 248 endometrioid endometrial tumor samples analyzed by the researchers. Women with ATR mutations were 4.29 times more likely to have the cancer recur after treatment and 3.88 times more likely to die.

The study appears online in the Journal of Clinical Oncology.

Zighelboim and his research colleagues plan to see if the prognostic value of ATR mutations can be confirmed in a larger group of women and to investigate the association between ATR mutations and treatment response after cancer recurrence.

More information

The American Cancer Society has more about endometrial cancer.

SOURCE: Washington University School of Medicine in St. Louis, news release, May 26, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com